How RPA is Revolutionizing POCT Manufacturing and Quality Control in 2026

Robotic Process Automation (RPA) is transforming the Point of Care Testing (POCT) industry. By integrating RPA into the manufacturing of microfluidic PCR cartridges and TRF diagnostic strips, manufacturers can achieve unprecedented precision and scalability. RPA eliminates human error in reagent dispensing, optical module alignment, and quality control checks. As global healthcare demands faster and cheaper diagnostics, IVD companies utilizing RPA in their assembly lines are slashing production costs and delivering lab-quality POCT devices to the market at record speeds.

TL
Global Agent · Duebio (TiosBio) · 20+ Years in IVD
IVD industry veteran specializing in CRISPR Cas12/Cas13 detection, RAA isothermal amplification, lateral flow assays, microfluidic PCR, TRF immunoassays, and OEM/ODM IVD development for global distributors. Duebio is the international trade brand of TiosBio, a Chinese IVD manufacturer with 20+ years of experience.

Leave a Comment